Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Liquidia Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Candel Therapeutics Inc. June 23, 202699.7%
-
Verrica Pharmaceuticals Inc. June 5, 202699.4%
-
Liquidia Corporation June 20, 202468.0%
-
Candel Therapeutics Inc. June 28, 202399.4%
-
Verrica Pharmaceuticals Inc. June 8, 202399.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Liquidia Corporation | Grant or award | +5,882 | — | — |
| Jun 4, 2026 | Liquidia Corporation | Open-market sale | −11,513 | $63.13 | $726,816 |
| Jun 4, 2026 | Liquidia Corporation | Open-market sale | −88,487 | $64.28 | $5,687,944 |
| Jun 4, 2026 | Liquidia Corporation | Open-market sale | −19,125 | $62.62 | $1,197,608 |
| Jun 4, 2026 | Liquidia Corporation | Open-market sale | −68,265 | $63.83 | $4,357,355 |
| Jun 4, 2026 | Liquidia Corporation | Open-market sale | −12,610 | $64.42 | $812,336 |
| Feb 23, 2026 | Candel Therapeutics Inc. | Open-market purchase | +550,458 | $5.45 | $2,999,996 |
| Feb 11, 2026 | Liquidia Corporation | Other | −55,116 | $42.63 | $2,349,595 |
| Feb 11, 2026 | Liquidia Corporation | Other | +55,116 | $42.63 | $2,349,595 |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc. | Open-market purchase | +1,375,380 | $4.24 | $5,831,611 |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc. | Open-market purchase | +2,750,762 | $4.24 | $11,663,231 |
| Sep 2, 2025 | Liquidia Corporation | Open-market sale | −254,038 | $28.67 | $7,283,269 |
| Sep 2, 2025 | Liquidia Corporation | Open-market sale | −74,230 | $29.14 | $2,163,062 |
| Aug 29, 2025 | Liquidia Corporation | Open-market sale | −188,232 | $27.62 | $5,198,968 |
| Aug 28, 2025 | Liquidia Corporation | Open-market sale | −154,337 | $27.94 | $4,312,176 |
Questions about Paul B. Manning
What boards is Paul B. Manning on?
Paul B. Manning sits on the boards of Candel Therapeutics Inc., Liquidia Corporation and Verrica Pharmaceuticals Inc.
How long has Paul B. Manning served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.